Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

Presentation Fellows 2021

Guides, Wires, Balloons

Presenter: Emmanouil S. Brilakis

May 09, 2021

News Daily News

CTO PCI: Lower Success, More Complications vs Other Complex PCI

Yael L. Maxwell

November 13, 2019

News Conference News TCT 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Yael L. Maxwell

October 30, 2017

News Daily News

Full Metal Jacket Approach Yields ‘Acceptable’ Long-term Outcomes in CTOs

Yael L. Maxwell

June 30, 2017

News Daily News

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

Caitlin E. Cox

March 10, 2017

News Daily News

推迟任意类型的支架患者的非心脏手术至少一年：登记表分析

L.A. McKeown

March 01, 2016

News Daily News

Postpone Noncardiac Surgery at Least a Year in Patients with Stents of Any Type: Registry Analysis

L.A. McKeown

March 01, 2016

News Daily News

Análisis de Registro: Postponer Cirugías No Cardíacas al Menos 1 Año en Pacientes Con Cualquier Tipo de Stents

L.A. McKeown

March 01, 2016

News Daily News

Los SLF y SMD son Ambos Aptos para el Tratamiento de Pacientes con Lesiones IVS

July 20, 2015

News Daily News

DES, BMS Both Suitable for Treating Patients With SVG Lesions

July 20, 2015

News Daily News

冠状动脉支架术后推迟 6 个月再进行非心脏手术可能减少并发症

L.A. McKeown

January 12, 2015

News Daily News

Retrasar la Cirugía No Cardíaca durante 6 Meses tras la Implantación de un Stent Coronario podría Reducir las Complicaciones

L.A. McKeown

January 12, 2015

News Daily News

Delaying Noncardiac Surgery for 6 Months After Coronary Stenting May Reduce Complications

L.A. McKeown

January 12, 2015

Presentation TCT 2014

Bare Metal and Drug-Eluting Stents: Devices, Indications, and Outcomes

Presenter: Emmanouil S. Brilakis, J. Dawn Abbott

September 13, 2014

Presentation TCT 2013

No! Aspirin and Ticagrelor Is a Much Better Option

Presenter: Emmanouil Brilakis

October 28, 2013

Presentation TCT 2012

Response of Endothelial Progenitor Cells To Antiproliferative Drugs Currently Used in Drug Eluting Stents

Presenter: Hao Xu, Kytai T. Nguyen, Lance S. Terada, Eric Fuh, Joseph A. Garcia, Emmanouil S. Brilakis, Deepak L. Bhatt, Subhash Banerjee

January 03, 2012

Presentation TCT 2012

Prospective Evaluation Of the Xience V Everolimus-Eluting Stent In Saphenous Vein Graft Atherosclerosis: the Xience V-SVG Angiographic Study.

Presenter: Emmanouil S. Brilakis, Aristotelis C. Papayannis, Abdul-rahman R. Abdel-karim, Tesfaldet T. Michael, Arif Mahmood, Lorenza B. Makke, Michele Roesle, Donald Haagen, Bavana V. Rangan, Subhash Banerjee

January 03, 2012

News Daily News

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Jason Kahn

September 12, 2011

Advertisement

Guides, Wires, Balloons

CTO PCI: Lower Success, More Complications vs Other Complex PCI

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Full Metal Jacket Approach Yields ‘Acceptable’ Long-term Outcomes in CTOs

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

推迟任意类型的支架患者的非心脏手术至少一年：登记表分析

Postpone Noncardiac Surgery at Least a Year in Patients with Stents of Any Type: Registry Analysis

Análisis de Registro: Postponer Cirugías No Cardíacas al Menos 1 Año en Pacientes Con Cualquier Tipo de Stents

Los SLF y SMD son Ambos Aptos para el Tratamiento de Pacientes con Lesiones IVS

DES、BMS 均适合治疗患隐静脉桥血管病变的患者

DES, BMS Both Suitable for Treating Patients With SVG Lesions

冠状动脉支架术后推迟 6 个月再进行非心脏手术可能减少并发症

Retrasar la Cirugía No Cardíaca durante 6 Meses tras la Implantación de un Stent Coronario podría Reducir las Complicaciones

Delaying Noncardiac Surgery for 6 Months After Coronary Stenting May Reduce Complications

Bare Metal and Drug-Eluting Stents: Devices, Indications, and Outcomes

No! Aspirin and Ticagrelor Is a Much Better Option

Response of Endothelial Progenitor Cells To Antiproliferative Drugs Currently Used in Drug Eluting Stents

Prospective Evaluation Of the Xience V Everolimus-Eluting Stent In Saphenous Vein Graft Atherosclerosis: the Xience V-SVG Angiographic Study.

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content